Prognostic implications of immune classification based on PD-L1 expression and tumor-infiltrating lymphocytes in endocervical adenocarcinoma
TMIT I group within the NHPVA population is most likely to benefit from PD-L1/PD-1 blockade immunotherapies. The immune classification of ECA demonstrates significant prognostic value, suggesting its potential utility in guiding clinical stratification and therapeutic decision-making.
Authors
- Lijun Wei (ORCID: https://orcid.org/0000-0002-5685-4940)
- Rongzhen Luo (ORCID: https://orcid.org/0000-0002-6599-0370)
- Liyan Wu (ORCID: https://orcid.org/0000-0002-4622-3125)
- Ying-Wen Wu
- Lili Liu (ORCID: https://orcid.org/0000-0002-4347-2038)
- Wu Zz
- Haoyu Liang
Institutions
- Sun Yat-sen University (CN)
- First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2024-12-29
- DOI
- https://doi.org/10.1016/j.tranon.2024.102265
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China